Davenport Huyer, Locke S

Published purpose

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation. This PA will fund Breast Cancer research in the following priority areas: • General Breast Cancer Research o research that supports CIHR-ICR’s mandate in the area of Breast Cancer. • Breast Cancer Prevention and/or Early Detection of Breast Cancer o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable. • Breast Cancer Survivorship o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages after cancer treatment ends. o specifically in the areas of: ¿ Late and long-term effects of cancer treatment ¿ Survivors’ experiences and outcomes ¿ Models of care for cancer survivorship o This PA will not fund research focused on improving end-of-life care. • This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.